Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512623003533 |
_version_ | 1797389473503248384 |
---|---|
author | Warner Robinson, DDS Beth N. McLellan, MD |
author_facet | Warner Robinson, DDS Beth N. McLellan, MD |
author_sort | Warner Robinson, DDS |
collection | DOAJ |
first_indexed | 2024-03-08T22:56:28Z |
format | Article |
id | doaj.art-64e264c7af0248079afc40a45b480e9b |
institution | Directory Open Access Journal |
issn | 2352-5126 |
language | English |
last_indexed | 2024-03-08T22:56:28Z |
publishDate | 2023-12-01 |
publisher | Elsevier |
record_format | Article |
series | JAAD Case Reports |
spelling | doaj.art-64e264c7af0248079afc40a45b480e9b2023-12-16T06:07:49ZengElsevierJAAD Case Reports2352-51262023-12-01423134Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritusWarner Robinson, DDS0Beth N. McLellan, MD1Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New YorkCorrespondence to: Beth N. McLellan, MD, Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York.; Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New Yorkhttp://www.sciencedirect.com/science/article/pii/S2352512623003533checkpoint inhibitordupilumabDupixentPD-1 inhibitorvitiligo |
spellingShingle | Warner Robinson, DDS Beth N. McLellan, MD Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus JAAD Case Reports checkpoint inhibitor dupilumab Dupixent PD-1 inhibitor vitiligo |
title | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
title_full | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
title_fullStr | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
title_full_unstemmed | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
title_short | Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
title_sort | incidental improvement of programmed cell death 1 receptor inhibitor induced vitiligo after initiation of dupilumab therapy for refractory pruritus |
topic | checkpoint inhibitor dupilumab Dupixent PD-1 inhibitor vitiligo |
url | http://www.sciencedirect.com/science/article/pii/S2352512623003533 |
work_keys_str_mv | AT warnerrobinsondds incidentalimprovementofprogrammedcelldeath1receptorinhibitorinducedvitiligoafterinitiationofdupilumabtherapyforrefractorypruritus AT bethnmclellanmd incidentalimprovementofprogrammedcelldeath1receptorinhibitorinducedvitiligoafterinitiationofdupilumabtherapyforrefractorypruritus |